|
【结 构 式】 
|
【分子编号】51235 【品名】4-chloro-6-[(E)-3-methyl-1-triazenyl]quinazoline 【CA登记号】 |
【 分 子 式 】C9H8ClN5 【 分 子 量 】221.64892 【元素组成】C 48.77% H 3.64% Cl 15.99% N 31.6% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号：(II)Arylamine (I) is converted into the corresponding methyltriazene (II) by formation of the corresponding diazonium salt with NaNO2 in HCl/H2O, followed by reaction with methylamine. Finally, the target compound is obtained by coupling of (II) with the corresponding amine in refluxing isopropanol.
| 【1】 Vaughan, K.; et al.; Studies of the model of action of antitumor triazenes and triazines. 6. 1-Ayl-3-(hydroxymethyl)-3-methyltriazenes: Synthesis, chemistry, and antitumor properties. J Med Chem 1984, 27, 3, 357. |
| 【2】 Rewcastle, G.W.; et al.; Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth f. J Med Chem 1995, 38, 18, 3482. |
Extended Information